06:00 – 06:45 PM – Opening Lecture “Tribute to Timothy Ray Brown”
06:00 – 06:15 PM – Welcoming message
David MARGOLIS, University of North Carolina at Chapel Hill, Chapel Hill, USA
Mario STEVENSON, University of Miami – Miller School of Medicine, Miami, USA
06:15- 06:45 PM – Lessons learned from allogeneic stem cell transplantation in HIV+ patients – Gero Hütter, Berlin, GER
07:00 PM – Welcome dinner
08:00 – 10:00 AM Session 1: Basic Science of HIV Persistence
Moderators: Maria Salgado, Barcelona – SPA, Nancy Archin, Chapell Hill – USA
1st lecturer: Consequences of Sequencing HIV – Sarah Palmer, Sydney – AUS
+ 7 oral communications
10:00 – 10:30 AM Break
10:30 AM – 12:30 PM Session 2: In Vitro and Animal Model Studies of HIV Persistence
Moderators: Ann Chahroudi, Yerkes – USA, Afam Okoye, Beaverton – USA
1st lecturer: CCR5 blockade in HIV cure – Jonah B. Sacha, Beaverton, USA
+ 7 oral communications
12:30 – 02:00 PM – Lunch
02:00 – 04:00 PM – Session 3: Virology of HIV Persistence
Moderators: Ya Chi Ho, Yale – USA, Mary Kearney, Frederick – USA
1st lecturer: Varying Susceptibility of HIV-1 to Type 1 Interferon Inhibition During Infection – Beatrice Hahn, Philadelphia, USA
+ 7 oral communications
04:00 – 07:30 PM – Poster session & free evening dinner
08:00 – 10:00 AM Session 4: Immunology of HIV Persistence
Moderators: Katharine Bar, Philadelphia – USA, Bradley Jones, New York – USA
1st lecturer: HIV persistence and NK cells – Michaela Muller-Trutwin, Paris, France
+ 7 oral communications
10:00 – 10:30 AM Break
10:30 AM – 12:30 PM Session 5: Drug Discovery Development & pharmacology
Moderators: Jan Van Luzen, London – GB, TBC
1st lecturer: IAP inhibitors to induce HIV expression- Richard Dunham, Chapel Hill, USA
+ 7 oral communications
12:30 – 02:00 PM – Lunch
02:00 – 04:00 PM – Session 6: Cell & gene therapies
Moderators: Javier Martinez-Picado, Badalona – ESP, Paula Cannon, Los Angeles – USA
1st lecturer: It’s a mountain not a hill: Progress made in realizing AAV-delivered inhibitors for an HIV cure – Mathew Gardner, Jupiter, USA
+ 7 oral communications
04:00 – 07:30 PM – Poster session & free evening dinner
08:00 – 10:00 AM Session 7: Human Studies
Moderators: TBC
1st lecturer: Challenges and Advances in Identification and Immune Targeting of HIV-Infected Cells: Implications for HIV Cure Therapies – Timothy Henrich, San Francisco, USA
+ 7 oral communications
10:00 – 10:30 AM Break
10:30 AM – 12:30 PM Session 8: Antibody & Immune based therapies
Moderators: Marina Caskey, Rockefeller – USA, Michael Farzan, San Diego – USA
1st lecturer: Broadly Neutralizing Antibodies for HIV Prevention, Therapy and Cure: 3BNC117 & 10-1074 Studies – Marina Caskey, New York , USA
+ 7 oral communications
12:30 – 01:00 PM – Closing ceremony
